Molecular imaging and fusion targeted biopsy of the prostate.

about

PET Molecular Imaging-Directed Biopsy: A Review.Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

P2860

Q39306671-C835B748-9021-4835-9747-08A0B7C44B8B Q39438297-2CFD92F6-4343-4FFC-BA65-5AEAB9ABB5E6

P2860

Molecular imaging and fusion targeted biopsy of the prostate.

Item

http://www.wikidata.org/entity/Q47608215

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Molecular imaging and fusion targeted biopsy of the prostate.

@en

Molecular imaging and fusion targeted biopsy of the prostate.

@nl

type

Item

label

Molecular imaging and fusion targeted biopsy of the prostate.

@en

Molecular imaging and fusion targeted biopsy of the prostate.

@nl

prefLabel

Molecular imaging and fusion targeted biopsy of the prostate.

@en

Molecular imaging and fusion targeted biopsy of the prostate.

@nl

P1476

Molecular imaging and fusion targeted biopsy of the prostate.

@en

P2093

Adeboye O Osunkoya

http://www.w3.org/2001/XMLSchema#string

Peter T Nieh

http://www.w3.org/2001/XMLSchema#string

Viraj A Master

http://www.w3.org/2001/XMLSchema#string

Yun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical application of a 3D ultrasound-guided prostate biopsy system

ESUR prostate MR guidelines 2012

Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer

Cancer statistics, 2015

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer.

P2888

s40336-016-0214-7

P304

29-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40336-016-0214-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Baowei Fei

David M Schuster

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971090

http://www.w3.org/2001/XMLSchema#string

P921

biopsy

P932

5621648

http://www.w3.org/2001/XMLSchema#string

Molecular imaging and fusion targeted biopsy of the prostate.

about

P2860

P2860

Molecular imaging and fusion targeted biopsy of the prostate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932